Embecta Corporation EMBC 深 沪
等待开盘 08-10 09:30:00 美东时间
4.42
+0.920
+26.29%
华盛通- 最 高4.69
- 今 开4.14
- 成交量 556.09万股
- 最 低 3.47
- 昨 收 3.50
- 总市值 25.55万
- 52周最高 15.55
- 市盈率 静 0.61
- 换手率 9621.21%
- 52周最低 2.77
- 委 比 0.89%
- 总股本 5.78万
- 历史最高 36.64
- 量 比 5.22
- 振 幅 34.86%
- 历史最低 1.10
- 每 手 1
- 风险率 4.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BTIG Downgrades Embecta to Neutral
BTIG analyst Marie Thibault downgrades Embecta (NASDAQ:EMBC) from Buy to Neutral.
05-06 17:34
Crude Oil Down 4%; PayPal Shares Fall After Q1 Results
US stocks rise, Nasdaq gains 1%. Dow up 0.57%, Nasdaq up 1.03%, S&P 500 up 0.84%. Materials up 2.1%, financials down 0.2%. PayPal shares fall 9%.
05-06 01:13
Under the Radar: Why "Fixing" a Great Strategy Usually Breaks It
The temptation to "fix" a great strategy is almost irresistible. Every week I r...
04-29 02:04
Embecta Agrees To Acquire Owen Mumford For £150M
Embecta Corp. ("Embecta") (NASDAQ:EMBC), a global leader in diabetes care technology, today announced that it has entered into a definitive agreement to acquire Owen Mumford Holdings Limited ("Owen Mumford"), a privately
03-19 18:33
Earnings Scheduled For February 5, 2026
Companies Reporting Before The Bell • WEC Energy Group (NYSE:WEC) is estimated ...
02-05 19:11
Embecta's Earnings: A Preview
Embecta (NASDAQ:EMBC) is preparing to release its quarterly earnings on Tuesday...
2025-11-24 23:03
Embecta Devdatt Kurdikar To Become Chairman Of Board
Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that David J. Albritton, a member of
2025-11-18 06:08
embecta to Participate in Investor Events
Embecta Corp. announced it will participate in several investor events in May and June 2025, including one-on-one meetings and fireside sessions at conferences in California, New York, Florida, and Boston.
2025-05-27 21:00
embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day
Embecta Corp. holds its first Analyst and Investor Day on May 22, 2025, to present its phased approach for value creation and long-range financial plan. The company focuses on strengthening its core insulin injection business, expanding its product portfolio, and enhancing financial flexibility. It reaffirms its 2025 financial guidance and long-term goals, including maintaining revenue growth, improving operating margins, and generating significant free cash flow.
2025-05-22 10:30
Sector Update: Health Care Stocks Decline Late Afternoon
04:00 PM EDT, 09/03/2024 (MT Newswires) -- Health care stocks fell late Tuesday afternoon with the NYSE Health Care Index shedding 0.5% and the Health Care Select Sector SPDR Fund (XLV) down 0.3%. The iShares Biotechnology ETF (IBB) dropped 1.8%. In corporate news, TC BioPharm (TCBP) shares jumped 2...
2024-09-04 04:00
